Resultats globals: 1 registres trobats en 0.02 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
13 p, 2.4 MB Histone variant MacroH2A1 is downregulated in prostate cancer and influences malignant cell phenotype / Vieira-Silva, T. S. (Portuguese Oncology Institute of Porto (IPO Porto)) ; Monteiro-Reis, S. (Portuguese Oncology Institute of Porto (IPO Porto)) ; Barros-Silva, D. (Portuguese Oncology Institute of Porto (IPO Porto)) ; Ramalho-Carvalho, J. (Portuguese Oncology Institute of Porto (IPO Porto)) ; Graça, I. (Portuguese Oncology Institute of Porto (IPO Porto)) ; Carneiro, I. (Department of Pathology. Portuguese Oncology Institute of Porto (IPO Porto)) ; Martins, A. T. (Department of Pathology. Portuguese Oncology Institute of Porto (IPO Porto)) ; Oliveira, Jorge (IPO-Porto. Department of Urology) ; Antunes, L. (Portuguese Oncology Institute of Porto (IPO Porto). Department of Epidemiology) ; Hurtado-Bagès, Sarah (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Buschbeck, Marcus (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Henrique, Rui (University of Porto. Department of Pathology and Molecular Immunology) ; Jerónimo, C. (University of Porto. Department of Pathology and Molecular Immunology) ; Universitat Autònoma de Barcelona
Background: Prostate cancer (PCa), a major cause of cancer-related morbidity and mortality worldwide and mostly asymptomatic at earliest stages, is characterized by disruption of genetic and epigenetic balance. [...]
2019 - 10.1186/s12935-019-0835-9
Cancer Cell International, Vol. 19 Núm. 1 (29 2019) , p. 112  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.